Evaluation of the Office on Violence Against Women's Domestic Violence Homicide Prevention Demonstrative Initiative (DVHPDI)

March 19, 2021 updated by: Yale University

Evaluation of the Domestic Violence Homicide Prevention Initiative

In collaboration with the National Institute of Justice (NIJ) and the Office for Violence Against Women (OVW) the Yale University team will evaluate the implementation process and impact of the U.S. Department of Justice's Domestic Violence Homicide Prevention Demonstration Initiative. This evaluation seeks to draw critical findings and potential lessons from the combined experience of the sites including: 1) how the models work in different communities; 2) the barriers and facilitators to implementing the models; and 3) outcomes of the model delivery. The evaluation team will also disseminate the findings with the goal of informing replication.

Study Overview

Detailed Description

Process Evaluation: The process evaluation will assess: 1) the training and technical assistance provided to sites; 2) the implementation of the models in the communities; and 3) characteristics of the service delivery systems.

Technical Assistance Providers will document the training and technical assistance (TTA) they provide to the sites.

Sites will be asked to identify key stakeholders to participate in interviews before the implementation begins and then two additional times during the demonstration phase. Key informant interviews will assess: recipient's perception of the training and technical assistance; model fidelity; model implementation (including model penetration, barriers and facilitators to implementation); and, perceptions of model impact. In addition to key informant interviews administrative data will be gathered to assess aspects of model implementation and systematic observations of law enforcement initiated screens will be conducted by a member of the evaluation team who will join patrol officers for "ride-alongs".

Impact Evaluation: The impact evaluation will assess changes in: 1) collaboration among service sectors; 2) supervision and sanctions for offenders; 3) recidivism and re-victimization; 4) victim reported feelings of safety; 5) utilization of resources; and 6) nature of safety planning.

System Collaboration will be assessed through a web-based survey completed at three time points by key stakeholders representing all potential partners in the community. Social network analysis will provide a visual depiction of how the network changes over time.

Victim Interviews will be conducted to determine the impact of involvement in the model program on their safety and wellbeing. Victims will be interviewed at three time points and will be asked about: prior and recent contact with law enforcement, domestic violence service providers or other providers; awareness of resources to address IPV; their safety and fear of their partner; coping strategies utilized; social support; financial resources; willingness to utilize criminal justice system and domestic violence service providers; both their and offenders behavior, beliefs and attitudes; self-reported mental health and substance abuse; their report of offenders substance abuse; and demographic information.

Administrative Data will be utilized to examine the breadth of the model implementation; the impact of the model programs on criminal justice processes; and whether there is a connection between the extent of post-risk assessment sanctions and services and the pattern of newly recorded incidents between the victim and offender. The evaluation will compare processing and outcomes across cases that are in many ways similar except that some cases were determined to be high risk and a risk assessment was completed and others where a risk assessment was not conducted. To facilitate these comparisons, the evaluation team will build a comprehensive database that will depict the "life-history" of each victim and offender dyad.

Study Type

Observational

Enrollment (Actual)

666

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Connecticut
      • New Haven, Connecticut, United States, 06511
        • Yale University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study will include all domestic violence offenders and victims within the six communities.

Description

The demonstration sites are:

California North Carolina Ohio Illinois Michigan Tennessee

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
California
Lethality Assessment Program
Law enforcement officers conduct risk screen of domestic violence victims, if high risk victims are referred to domestic violence services.
Other Names:
  • LAP
North Carolina
Lethality Assessment Program
Law enforcement officers conduct risk screen of domestic violence victims, if high risk victims are referred to domestic violence services.
Other Names:
  • LAP
Ohio
Domestic Violence High Risk Team
Law enforcement officers conduct risk screen of domestic violence victims, if high risk victims are referred to domestic violence services and a team who monitors the clinical and criminal justice progress.
Other Names:
  • HRT
Illinois
Lethality Assessment Program
Law enforcement officers conduct risk screen of domestic violence victims, if high risk victims are referred to domestic violence services.
Other Names:
  • LAP
Michigan
Lethality Assessment Program
Law enforcement officers conduct risk screen of domestic violence victims, if high risk victims are referred to domestic violence services.
Other Names:
  • LAP
Tennessee
Lethality Assessment Program
Law enforcement officers conduct risk screen of domestic violence victims, if high risk victims are referred to domestic violence services.
Other Names:
  • LAP

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Decreased frequency of re-assault
Time Frame: up to 3 years
Decrease in harassment, assault, injury, homicide/mortality
up to 3 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Increased collaboration between network partners
Time Frame: up to 3 years
Increased information sharing, case planning, coordinated response
up to 3 years
Increased awareness of and utilization of resources for victims
Time Frame: Up to 3 years
Increased awareness of and utilization of community resources
Up to 3 years
Increased safety planning
Time Frame: Up to 3 years
Increased safety planning at the time of police intervention
Up to 3 years
Increased victim reported safety
Time Frame: Up to 3 years
Victim reported changes in perceptions of safety
Up to 3 years
Increased sanctions for offender
Time Frame: Up to 3 years
Sanctions such as pre-trial containment, cases to trial, adjudications, containment post-adjudication
Up to 3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Joy S Kaufman, PhD, Yale University
  • Study Director: Christopher Maxwell, PhD, Michigan State University
  • Study Director: Tami Sullivan, PhD, Yale University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2014

Primary Completion (Actual)

December 31, 2020

Study Completion (Actual)

December 31, 2020

Study Registration Dates

First Submitted

December 12, 2013

First Submitted That Met QC Criteria

December 19, 2013

First Posted (Estimate)

December 27, 2013

Study Record Updates

Last Update Posted (Actual)

March 24, 2021

Last Update Submitted That Met QC Criteria

March 19, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 1311013010

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data will be archived with the National Institute of Justice

IPD Sharing Time Frame

before December 31, 2020

IPD Sharing Access Criteria

To be determined

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Domestic Violence

Clinical Trials on Lethality Assessment Program

Subscribe